iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

DOI Web Site Web Site 37 Citations

Journal

The Lancet Oncology

The Lancet Oncology 18 (3), e143-e152, 2017-03

Elsevier BV

Citations (37)*help

See more

Details 詳細情報について

CRID

1363388843948887552
DOI

10.1016/s1470-2045(17)30074-8
ISSN

14702045
Web Site

https://api.elsevier.com/content/article/PII:S1470204517300748?httpAccept=text/plain

https://api.elsevier.com/content/article/PII:S1470204517300748?httpAccept=text/xml
Data Source
- Crossref

Export

Report a problem

Back to top